These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 25370553

  • 1. Resolution of granuloma annulare following treatment with bendamustine and rituximab in a patient with follicular lymphoma: a serendipitous finding.
    Shah BK, Hewett Y, Peterson A, Tretheway D.
    J Postgrad Med; 2014; 60(4):406-8. PubMed ID: 25370553
    [Abstract] [Full Text] [Related]

  • 2. [Recent therapeutic strategy for follicular lymphoma].
    Ogura M.
    Nihon Naika Gakkai Zasshi; 2007 Apr 10; 96(4):787-804. PubMed ID: 17506321
    [No Abstract] [Full Text] [Related]

  • 3. Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma.
    Carter SJ, Bernstein SH, Friedberg JW, Barr PM.
    Leuk Res; 2011 Nov 10; 35(11):e223-4. PubMed ID: 21824654
    [No Abstract] [Full Text] [Related]

  • 4. The emerging role of bendamustine in follicular lymphoma.
    Friedberg JW.
    Leuk Lymphoma; 2009 Mar 10; 50(3):317-8. PubMed ID: 19347722
    [No Abstract] [Full Text] [Related]

  • 5. Bendamustine and rituximab for indolent B-cell non-hodgkin lymphoma in patients with compensated hepatitis C cirrhosis: a case series.
    Parker SM, Hyder MA, Fesler MJ.
    Clin Lymphoma Myeloma Leuk; 2013 Dec 10; 13(6):e15-7. PubMed ID: 24060287
    [No Abstract] [Full Text] [Related]

  • 6. HBV reactivation in malignant lymphoma patients treated with rituximab and bendamustine.
    Tsutsumi Y, Ogasawara R, Miyashita N, Tanaka J, Asaka M, Imamura M.
    Int J Hematol; 2012 May 10; 95(5):588-91. PubMed ID: 22419099
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Follicular lymphoma.
    Ghielmini M.
    Ann Oncol; 2010 Oct 10; 21 Suppl 7():vii151-3. PubMed ID: 20943608
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous occurrence of large B-cell non-Hodgkin lymphoma and acute myeloid leukaemia in an elderly patient: complete remissions of both diseases by rituximab-bendamustine regimen combined to hypomethylating therapy.
    Palombi M, Niscola P, Tendas A, Trawinska MM, Scaramucci L, Giovannini M, Fratoni S, Perrotti A, de Fabritiis P.
    J Chemother; 2013 Aug 10; 25(4):247-9. PubMed ID: 23906078
    [Abstract] [Full Text] [Related]

  • 13. Generalized granuloma annulare and non-Hodgkin's lymphoma.
    Bassi A, Scarfi F, Galeone M, Arunachalam M, Difonzo E.
    Acta Derm Venereol; 2013 Jul 06; 93(4):484-5. PubMed ID: 23250047
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma.
    Ogura M, Ando K, Taniwaki M, Watanabe T, Uchida T, Ohmachi K, Matsumoto Y, Tobinai K, Japanese Bendamustine Lymphoma Study Group.
    Cancer Sci; 2011 Sep 06; 102(9):1687-92. PubMed ID: 21624007
    [Abstract] [Full Text] [Related]

  • 16. Rituximab plus bendamustine for the treatment of aggressive non-hodgkin lymphoma patients with severe liver impairment.
    Ogura M.
    Clin Adv Hematol Oncol; 2013 Mar 06; 11(3):188-9. PubMed ID: 23598989
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of recalcitrant generalized granuloma annulare with adalimumab.
    Torres T, Pinto Almeida T, Alves R, Sanches M, Selores M.
    J Drugs Dermatol; 2011 Dec 06; 10(12):1466-8. PubMed ID: 22134573
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Alleviated anemia by bendamustine in cold agglutinin disease associated with small lymphocytic lymphoma].
    Kuno M, Inoue A, Aimoto M, Nakao T, Kameda K, Yoshida M, Kanashima H, Hirai M, Yamane T.
    Rinsho Ketsueki; 2015 Feb 06; 56(2):204-9. PubMed ID: 25765801
    [Abstract] [Full Text] [Related]

  • 20. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
    Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Dürk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W, Study group indolent Lymphomas (StiL).
    Lancet; 2013 Apr 06; 381(9873):1203-10. PubMed ID: 23433739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.